User login
Article Type
Changed
Wed, 12/01/2021 - 11:52
Insights gained over the past two decades about idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) have greatly advanced our understanding of these conditions and have helped facilitate earlier diagnosis and intervention and improvements to patient care. Recently, the concept of progressive fibrosing ILD has emerged, as many patients with fibrosing ILDs show rapid deterioration similar to IPF, thereby requiring close monitoring.
This publication explores fibrosing ILDs, in recognition of the need for further education about these conditions.
Read More
Sponsor
This publication was funded by Boehringer Ingelheim Pharmaceuticals, Inc.
Publications
Sponsor
This publication was funded by Boehringer Ingelheim Pharmaceuticals, Inc.
Sponsor
This publication was funded by Boehringer Ingelheim Pharmaceuticals, Inc.
Insights gained over the past two decades about idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) have greatly advanced our understanding of these conditions and have helped facilitate earlier diagnosis and intervention and improvements to patient care. Recently, the concept of progressive fibrosing ILD has emerged, as many patients with fibrosing ILDs show rapid deterioration similar to IPF, thereby requiring close monitoring.
This publication explores fibrosing ILDs, in recognition of the need for further education about these conditions.
Read More
Insights gained over the past two decades about idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) have greatly advanced our understanding of these conditions and have helped facilitate earlier diagnosis and intervention and improvements to patient care. Recently, the concept of progressive fibrosing ILD has emerged, as many patients with fibrosing ILDs show rapid deterioration similar to IPF, thereby requiring close monitoring.
This publication explores fibrosing ILDs, in recognition of the need for further education about these conditions.
Read More
Publications
Publications
Article Type
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Information from Industry- Sponsored Content
Consolidated Pubs: Do Not Show Source Publication Logo
Use ProPublica
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article